The dopaminergic nigrostriatal system: development, physiology, disease Oliver von Bohlen und HalbachKerstin KrieglsteinJörg B. Schulz Editorial 01 September 2004 Pages: 3 - 3
Midbrain-derived neural stem cells: from basic science to therapeutic approaches Alexander StorchMichael SabolekJohannes Schwarz Review 29 July 2004 Pages: 15 - 22
Induction and specification of midbrain dopaminergic cells: focus on SHH, FGF8, and TGF-β Eleni RoussaKerstin Krieglstein Review 19 August 2004 Pages: 23 - 33
Homeobox gene Pitx3 and its role in the development of dopamine neurons of the substantia nigra Marten P. SmidtSimone M. SmitsJ. Peter H. Burbach Review 06 August 2004 Pages: 35 - 43
Nurr1, an orphan nuclear receptor with essential functions in developing dopamine cells Thomas PerlmannÅsa Wallén-Mackenzie Review 01 September 2004 Pages: 45 - 52
Midbrain dopaminergic neurons: control of their cell fate by the engrailed transcription factors Horst H. SimonSandrine ThuretLavinia Alberi Review 01 September 2004 Pages: 53 - 61
Ontogenic cell death in the nigrostriatal system Robert E. Burke Review 03 September 2004 Pages: 63 - 72
Factors promoting survival of mesencephalic dopaminergic neurons Kerstin Krieglstein Review 06 August 2004 Pages: 73 - 80
Histological changes of the dopaminergic nigrostriatal system in aging A. K. StarkB. Pakkenberg Review 08 September 2004 Pages: 81 - 92
Contrast enhancement: a physiological effect of striatal dopamine? Saleem M. NicolaF. Woodward HopfGregory O. Hjelmstad Review 28 July 2004 Pages: 93 - 106
Stages in the development of Parkinson’s disease-related pathology Heiko BraakEstifanos GhebremedhinKelly Del Tredici Review 24 August 2004 Pages: 121 - 134
Neuronal pathology in Parkinson’s disease Jörg B. SchulzBjörn H. Falkenburger Review 08 September 2004 Pages: 135 - 147
Cellular pathology of Parkinson’s disease: astrocytes, microglia and inflammation Peter TeismannJörg B. Schulz Review 24 August 2004 Pages: 149 - 161
Synucleins and their relationship to Parkinson’s disease Oliver von Bohlen und Halbach Review 24 July 2004 Pages: 163 - 174
Parkin-associated Parkinson’s disease Rainer von CoellnValina L. DawsonTed M. Dawson Review 30 July 2004 Pages: 175 - 184
Causes of Parkinson’s disease: genetics of DJ-1 Patrick M. Abou-SleimanDaniel G. HealyNicholas W. Wood Review 26 June 2004 Pages: 185 - 188
Genetic causes of Parkinson’s disease: UCHL-1 Daniel G. HealyPatrick M. Abou-SleimanNicholas W. Wood Review 19 June 2004 Pages: 189 - 194
The role of synphilin-1 in synaptic function and protein degradation Rejko Krüger Review 19 August 2004 Pages: 195 - 199
Redox imbalance Daniela BergMoussa B. H. YoudimPeter Riederer Review 10 September 2004 Pages: 201 - 213
Classic toxin-induced animal models of Parkinson’s disease: 6-OHDA and MPTP Andreas Schober Review 28 July 2004 Pages: 215 - 224
Neurotoxicant-induced animal models of Parkinson’s disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration Vladimir N. Uversky Review 16 July 2004 Pages: 225 - 241
Stem cell therapy for Parkinson’s disease: where do we stand? Laurent RoybonNicolaj S. ChristophersenJia-Yi Li Review 11 August 2004 Pages: 261 - 273
Deep brain stimulation Sorin BreitJörg B. SchulzAlim-Louis Benabid Review 19 August 2004 Pages: 275 - 288